AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
+0.33%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$2.14B
AUM Growth
+$2.14B
(+13%)
Cap. Flow
+$249M
Cap. Flow
% of AUM
11.63%
Top 10 Holdings %
Top 10 Hldgs %
28.35%
Holding
124
New
45
Increased
32
Reduced
15
Closed
23
Top Buys
| 1 |
Williams-Sonoma
WSM
|
$40.2M |
| 2 |
Alkermes
ALKS
|
$35.2M |
| 3 |
Coca-Cola
KO
|
$32M |
| 4 |
SPPI
Spectrum Pharmaceuticals Inc
SPPI
|
$30.9M |
| 5 |
AutoZone
AZO
|
$27.4M |
Top Sells
| 1 |
Dropbox
DBX
|
$35.4M |
| 2 |
Dollar General
DG
|
$35.3M |
| 3 |
Biogen
BIIB
|
$32.9M |
| 4 |
AptarGroup
ATR
|
$32.3M |
| 5 |
Five Below
FIVE
|
$32.2M |
Sector Composition
| 1 | Healthcare | 61.96% |
| 2 | Consumer Discretionary | 15.53% |
| 3 | Consumer Staples | 12.61% |
| 4 | Industrials | 3.06% |
| 5 | Technology | 1.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Avalo Therapeutics
AVTX
$122M
| $68.3M | 2.48% | 30,014,285 +100,000 | +0.3% | +$227K |
|
2
Supernus Pharmaceuticals
SUPN
$2.53B
| $66.7M | 2.42% | 3,200,000 +992,000 | +45% | +$20.7M |
|
3
Energizer
ENR
$1.88B
| $65.7M | 2.38% | 1,678,000 +530,000 | +46% | +$20.7M |
|
4
Lantheus
LNTH
$3.73B
| $61.3M | 2.22% | 4,836,000 +1,212,000 | +33% | +$15.4M |
|
|
5
AutoZone
AZO
$70.2B
| $60.4M | 2.19% | 51,291 +23,291 | +83% | +$27.4M |
|
6
Bristol-Myers Squibb
BMY
$96B
| $60.3M | 2.19% | 1,000,000 | – | – |
|
|
BHVN
7
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $58.5M | 2.12% | 900,000 +400,000 | +80% | +$26M |
|
|
ALXN
8
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $57.2M | 2.08% | 500,000 | – | – |
|
9
Incyte
INCY
$16.5B
| $57.1M | 2.07% | 636,000 +200,000 | +46% | +$17.9M |
|
10
Vanda Pharmaceuticals
VNDA
$279M
| $52.6M | 1.91% | 5,450,000 +650,000 | +14% | +$6.28M |
|
11
Regeneron Pharmaceuticals
REGN
$61.5B
| $47M | 1.71% | 84,000 +16,000 | +24% | +$8.96M |
|
12
UnitedHealth
UNH
$281B
| $46.8M | 1.7% | 150,000 -50,000 | -25% | -$15.6M |
|
13
Medtronic
MDT
$119B
| $44.5M | 1.61% | 428,000 -164,000 | -28% | -$17M |
|
14
Campbell Soup
CPB
$9.52B
| $44.3M | 1.61% | 916,000 +480,000 | +110% | +$23.2M |
|
15
Merck
MRK
$210B
| $43.5M | 1.58% | 524,000 +164,000 | +46% | +$13.6M |
|
|
BLUE
16
DELISTED
bluebird bio
BLUE
| $43.2M | 1.57% | 800,000 +232,000 | +41% | +$12.5M |
|
17
Ross Stores
ROST
$48.1B
| $41.1M | 1.49% | 440,000 +30,656 | +7% | +$2.86M |
|
|
18
Williams-Sonoma
WSM
$23.1B
| $40.2M | 1.46% | +445,000 | New | +$40.2M |
|
|
AMAG
19
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $38.7M | 1.4% | 4,120,000 | – | – |
|
|
20
Alkermes
ALKS
$4.78B
| $35.2M | 1.28% | +2,124,000 | New | +$35.2M |
|
21
Central Garden & Pet Class A
CENTA
$2.08B
| $35.1M | 1.27% | 972,000 -352,000 | -27% | -$12.7M |
|
22
Lowe's Companies
LOW
$145B
| $34.2M | 1.24% | 206,340 +70,924 | +52% | +$11.8M |
|
23
Frontdoor
FTDR
$4.43B
| $33.9M | 1.23% | 872,000 +280,000 | +47% | +$10.9M |
|
24
PTC Therapeutics
PTCT
$3.92B
| $33.8M | 1.23% | 724,000 +224,000 | +45% | +$10.5M |
|
25
Zymeworks
ZYME
$1.12B
| $33.4M | 1.21% | 716,000 -62,000 | -8% | -$2.89M |
|